| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Health Care Equipment & Supplies (Health Care sector), LAB's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 72.10M | $57.75M | - | |
| CEO | 6.24M | $4.99M | - | |
| CFO | 2.56M | $2.05M | - | |
| VP | 1.51M | $1.21M | - | |
| Dir | 344.5K | $275.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2017 | Levin Capital Strategies, L.P. | 10% Owner, Passive Investor | Buy | 1,549 | $3.18 | $4,931.71 | - | |
| Aug 8, 2017 | Linthwaite Stephen Christopher | President &CEO | Buy | 45,000 | $2.66 | $119,884.50 | +72.6% | |
| Aug 8, 2017 | Jog Vikram | Chief Financial Officer | Buy | 50,000 | $2.71 | $135,305.00 | +2,426% | |
| Aug 8, 2017 | McPhail Steven | Chief Commercial Officer | Buy | 20,000 | $3.00 | $60,032.00 | +255.0% | |
| Aug 8, 2017 | Colella Samuel D | Director | Buy | 35,895 | $2.77 | $99,357.36 | +205.1% | |
| Jun 7, 2017 | Jones Evan/ Fa70 | Director | Sell | 10,900 | $4.54 | $49,510.75 | -9.1% | |
| May 9, 2017 | Colella Samuel D | Director | Buy | 7,500 | $5.93 | $44,437.50 | +75.0% | |
| Mar 14, 2017 | Colella Samuel D | Director | Buy | 10,000 | $5.00 | $49,973.00 | New | |
| Dec 14, 2016 | Colella Samuel D | Director | Buy | 5,000 | $7.39 | $36,935.00 | +12.8% | |
| Nov 30, 2016 | Linthwaite Stephen Christopher | President &CEO | Buy | 55,000 | $6.36 | $350,064.00 | +1,833% |